Baxter International, Inc. finds itself embroiled in a significant legal battle as a class action lawsuit has been filed against the company. The lawsuit, which targets the period between February 23, 2022, and July 30, 2025, seeks to recover losses for shareholders affected by alleged securities fraud. At the heart of the case is Baxter’s Novum LVP, a medical device that has reportedly caused serious harm due to systemic defects.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The complaint alleges that Baxter misled investors by concealing critical information about the Novum LVP’s performance. The device, intended to regulate fluid delivery, reportedly suffered from severe malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids. These issues have allegedly led to multiple injuries and even deaths, raising serious concerns about patient safety.
Despite being aware of these malfunctions, Baxter’s efforts to address the defects through customer alerts were deemed insufficient. The persistent design flaws not only endangered patients but also threatened the company’s sales prospects, as customers were advised to discontinue the use of the faulty devices.
For those who have experienced financial losses due to this situation, there is an opportunity to seek recovery. Shareholders who held Baxter stock during the specified period are encouraged to visit [this link](https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?wire=18) to learn more about their rights. Participation comes with no cost or obligation.
The lawsuit is spearheaded by Levi & Korsinsky LLP, a firm with a formidable reputation in securities litigation. With over 20 years of experience and a proven track record of securing substantial settlements for shareholders, Levi & Korsinsky is well-equipped to handle this high-stakes case.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171